Science CAR-T Therapies Show Promise in Treating Autoimmune Disorders Experimental CAR-T therapies developed by Cabaletta Bio and Bristol Myers Squibb have demonstrated the ability to induce complete remissions in patients suffering from severe... Editorial5 hours ago